4.27
-0.03 (-0.7%)
-0.03 (-0.7%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eloxx Pharmaceuticals Inc | ELOX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.03 | -0.7% | 4.27 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.24 | 4.05 | 4.55 | 4.27 | 4.30 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.93 | 5.50 | 1.57 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 667 | 98,401 | $ 4.26 | $ 418,868 | 388,750 | 1.44 - 6.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:03 | 2 | $ 4.27 | USD |
Eloxx Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 171.45M | 40.15M | 28.27M | $ - | $ - | -1.34 | -4.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Eloxx Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELOX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.75 | 4.98 | 3.5847 | 4.30 | 177,905 | 0.52 | 13.87% |
| 1 Month | 3.64 | 4.98 | 3.43 | 4.12 | 93,639 | 0.63 | 17.31% |
| 3 Months | 2.90 | 6.77 | 2.83 | 3.98 | 241,231 | 1.37 | 47.24% |
| 6 Months | 2.99 | 6.77 | 2.39 | 3.80 | 130,715 | 1.28 | 42.81% |
| 1 Year | 3.20 | 6.77 | 1.44 | 3.36 | 124,961 | 1.07 | 33.44% |
| 3 Years | 10.35 | 24.60 | 1.44 | 7.52 | 121,669 | -6.08 | -58.74% |
| 5 Years | 10.35 | 24.60 | 1.44 | 7.52 | 121,669 | -6.08 | -58.74% |
Eloxx Pharmaceuticals Description
| Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. |
